Amy Raskin, CIO, Chevy Chase Trust

She bought it around $12-15. She trimmed her holding because it's highly volatile, though huge upside is possible. Likes it overall.

Likes it long term. China is 7% of their sales and has been declining the past 3 years. Has $1 billion in free cash flow a year. A high gross-margin business but it will be noisy for a while.

She trimmed it because it's up 20% this year because of the launch of their pain medicine. Tonight's earnings will be fine and their pipeline makes it a good stock long term.

Trimmed it because it moved up 145% the past year. They have a great franchise in cancer detection recurrence. Likes it long-term.

She just bought it. Their new technology offers a cheaper, better way to test blood to see if a body will accept/reject an organ. Biopsies are covered by insurance. Has a runway.

She added more after a moonshot last year, but has come back after a little excess inventory. Likes it long term.

It's lost a third of its market cap and the selling is overdone. Now, is a buying opportunity.

It reports next week. It remains her largest position, despite regular trimming. NVDA will continue to increase until they eat into the backlog sometime in the future.

It's had bad news this week, but it rarely gets a pull back. Long term this is fine.

If the Chinese consumer continues to recover, EL will do well. But even with the stimulus announced in China this week, China won't come roaring back.

She trimmed it a while ago. It's been terrible all year. There's no more pent-up demand. The aspirational buyers happened during the pandemic when consumers were flush. This will struggle for a little while.

She sold it last spring. It's good that they changed the CEO. Wait and see. They have lost so much market share. They need new product.

Likes it. The Frontier acquisitions was smart. The stock is cheap.

She owned this at $50 and is now $269, so she trimmed to take profits. Are well-positioned for the long term, but the PE is not cheap.

Likes the energy space. Shell is cheap compared to its peers. Boasts a 12% free cash flow yield.